Literature DB >> 2530474

Evidence for a widespread dopaminergic innervation of the human cerebral neocortex.

J De Keyser1, G Ebinger, G Vauquelin.   

Abstract

The recent finding that D1 dopamine receptors are present in all neocortical areas of the human brain, does not fit in with the generally held view that the mesocortical dopaminergic pathway is restricted to prefrontal areas. We investigated the brains of 3 patients who died with a unilateral infarction in the ventral midbrain, including the substantia nigra and ventral tegmental area. Compared to the intact side, the D1 receptors in frontal, temporal, parietal and occipital cortices and caudate nucleus at the lesioned side were increased by 27-37%, which is consistent with an up-regulation in response to a depletion of dopamine. These data provide evidence for a more widespread dopaminergic innervation of the human neocortex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530474     DOI: 10.1016/0304-3940(89)90589-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?

Authors:  Anissa Abi-Dargham
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

2.  D1- versus D2-receptor modulation of visuospatial working memory in humans.

Authors:  U Müller; D Y von Cramon; S Pollmann
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

3.  Retinal dysfunction of contrast processing in major depression also apparent in cortical activity.

Authors:  Emanuel Bubl; Elena Kern; Dieter Ebert; Andreas Riedel; Ludger Tebartz van Elst; Michael Bach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-08       Impact factor: 5.270

Review 4.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

Review 5.  Sleep disorders in patients with Parkinson's disease: epidemiology and management.

Authors:  J P Larsen; E Tandberg
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Abnormalities in the Fractional Amplitude of Low-Frequency Fluctuation and Functional Connectivity in Parkinson's Disease With Excessive Daytime Sleepiness.

Authors:  Yuheng Zi; Sainan Cai; Changlian Tan; Tianyu Wang; Qin Shen; Qinru Liu; Min Wang; Junli Li; Lin Zhang; Fan Zhou; Chendie Song; Jiaying Yuan; Yujing Liu; Jun Liu; Haiyan Liao
Journal:  Front Aging Neurosci       Date:  2022-07-05       Impact factor: 5.702

Review 7.  Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

Authors:  Robert W Buchanan; Robert Freedman; Daniel C Javitt; Anissa Abi-Dargham; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2007-07-19       Impact factor: 9.306

8.  Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease.

Authors:  F Sartucci; G Orlandi; U Bonuccelli; D Borghetti; L Murri; C Orsini; L Domenici; V Porciatti
Journal:  Neurol Sci       Date:  2006-02       Impact factor: 3.307

Review 9.  A review of brain circuitries involved in stuttering.

Authors:  Anna Craig-McQuaide; Harith Akram; Ludvic Zrinzo; Elina Tripoliti
Journal:  Front Hum Neurosci       Date:  2014-11-17       Impact factor: 3.169

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.